Novo Nordisk A/S
NVO
•Stock Analysis$54.37
+0.00 (+0.00%)• Live
Novo Nordisk A/S Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Novo Nordisk A/S
Key Financial Metrics
for Novo Nordisk A/S
P/E Ratio
21.88
Revenue Growth
+25.03%
EPS Growth
+142.85%
Market Cap
$2,306.59B
Dividend Yield
+2.21%
Debt/Equity
0.86
ROIC
+38.75%
FCF Yield
+3.24%
View additional metrics
Valuation
P/B Ratio16.52
EV/Sales7.87
Financial Health
Current Ratio0.74
Return on Assets+27.55%
Analyst Recommendations
for Novo Nordisk A/S
39 analysts
Consensus: Buy
About
for Novo Nordisk A/S
Company Details
for Novo Nordisk A/S
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Lars Fruergaard Jorgensen
Employees
77,406
Market Cap
241.60B
Exchange
New York Stock Exchange
IPO Date
April 30, 1981
Website
www.novonordisk.comCIK
0000353278
ISIN
US6701002056
CUSIP
670100205
Country
DK
Balance Sheet
for Novo Nordisk A/S
Cash Flow Statement
for Novo Nordisk A/S
Income Statement
for Novo Nordisk A/S
News
No news available at the moment.